AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.5900
+0.0105 (1.81%)
At close: Apr 1, 2025, 4:00 PM
0.6000
+0.0100 (1.69%)
After-hours: Apr 1, 2025, 4:19 PM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $6.21 million as of April 1, 2025. Its market cap has decreased by -98.68% in one year.
Market Cap
6.21M
Enterprise Value
19.05M
1-Year Change
-98.68%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $6.21M, a decrease of -90.24%. That is a compound annual growth rate of -44.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 6.10M | -71.72% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |